Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

USAISR completes OxyBand wound dressing study

The United States Army Institute of Surgical Research (USAISR) has completed a clinical trial of OxyBand Technologies' OxyBand wound dressing, designed to deliver therapeutic pure oxygen to damaged tissue.

By using a directional permeable gas-emitting reservoir, pure oxygen is packaged into a discrete wound dressing to heal wounds faster with significantly less pain and inflammation.

The USAISR clinical trial assessed the efficacy of OxyBand wound dressing compared to the standard dressing.

Oxyband Technologies founder and CEO Amie Franklin said the company is grateful to the US Army Institute for Surgical Research and the burn center for conducting the clinical trial to compare OxyBand Wound Dressing to standard care.

"We are honored to have partnered with the U.S. Army USISR, a Center of Excellence for Battlefield Health, Trauma and Burn Research and Care," Franklin added.

USAISR said it will present the results of OxyBand wound dressing at the Military Health System Research Symposium (MHSRS) held between 13 -16 August 2012 at the Harbor Beach Marriott Hotel in Fort Lauderdale, Florida, US.

OxyBand Wound Dressings will be available through McKesson-Medical Surgical, a medical distributor of vital medicines, medical supplies and information technologies, according to the company.